Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptors

Authors:

Abstract
No abstract available
All Related Versions
Funding Information
  • UKRI | Medical Research Council (MR/R010676/1)
  • Academy of Medical Sciences (N/A)
  • Society for Endocrinology (N/A)
  • British Society for Neuroendocrinology (N/A)
  • European Association for the Study of Diabetes (N/A)
  • UKRI | Engineering and Physical Sciences Research Council (N/A)
  • Diabetes UK (N/A)
  • Diabetes UK (BDA/11/0004210 BDA/15/0005275 BDA 16/0005485)
  • Wellcome (212625/Z/18/Z)
  • UKRI | Medical Research Council (MR/R022259/1 DIVA MR/L02036X/1)
  • Innovative Medicines Initiative (RHAPSODY grant No 115881)
  • FP7 Health (2009-241592 EuroCHIP)
  • Fondation de la Recherche Médicale (Equipe FRM DEQ20130326503 EQU201903008055)
  • Agence Nationale de la Recherche (ANR-2011-BSV1-012-01 “MLT2D” and ANR-2011-META “MELA-BETES ANR-19-CE16-0025-01 ANR-15-CE14-0025-02)
  • Institut National de la Santé et de la Recherche Médicale (N/A)
  • Centre National de la Recherche Scientifique (N/A)
  • Japan Agency for Medical Research and Development (PRIME JP19gm5910013 LEAP JP19gm0010004)

This publication has 83 references indexed in Scilit: